Related content

Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: A single center experience

By Nishikawa Hiroki   Tsudo Mitsuru   Osaki Yukio  

Oncology Reports, Vol. 28, Iss. 3, 2012-09 ,pp. : 835-840

Spandidos Publications

Access to resources Recommend Favorite

Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy

By                          

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 109-114

Spandidos Publications

Access to resources Recommend Favorite

The V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal

By  

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 958-966

Spandidos Publications

Access to resources Recommend Favorite

Epstein-Barr virus and human T-cell lymphomas

By Meijer C.J.L.M.   Jiwa N.M.   Dukers D.F.   Oudejans J.J.   de Bruin P.C.   Walboomers J.M.M.   van den Brule A.J.C.  

Seminars in Cancer Biology, Vol. 7, Iss. 4, 1996-04 ,pp. : 191-196

Academic Press

Access to resources Recommend Favorite

T-Cell-Rich B-Cell Lymphoma and Epstein-Barr Virus Infection of the Uterus in a Postmenopausal Patient with an Intrauterine Contraceptive Device in Place for over 20 Years

By Gutman P.D.   Williams J.P.   Dveksler G.S.   Hoffmeister K.   Cotelingam J.D.  

Gynecologic Oncology, Vol. 68, Iss. 3, 1998-03 ,pp. : 288-292

Elsevier

Access to resources Recommend Favorite